Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes

Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes

US Patent 9067898 · Granted Jun 30, 2015

Estimated economic value: $80,032,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Account identifier digitization abstraction2022
Functionalized erythroid cells2021
Cyclohexyl GPR40 agonists for the treatment of type II diabetes2021
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2020
GPR120 agonists for the treatment of type II diabetes2020
Pyridin-2-one derivatives of formula (I) useful as EP3 receptor antagonists2020
Account identifier digitization abstraction2019
Pyridin-2-one derivatives of formula (III) useful as EP3 receptor antagonists2019
Pyridin-2-one derivatives of formula (II) useful as EP3 receptor antagonists2019
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2018
GPR120 agonists for the treatment of type II diabetes2018
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2018